paroxetine has been researched along with alprazolam in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 16 (57.14) | 29.6817 |
| 2010's | 9 (32.14) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Artursson, P; Mateus, A; Matsson, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Court, MH; Duan, SX; Greenblatt, DJ; Harmatz, JS; Shader, RI; von Moltke, LL | 1 |
| Hartman, EE; Parker, RA | 1 |
| Rickels, K; Rynn, M | 1 |
| Barbanoj, M; Calvo, G; Dal-Ré, R; García-Gea, C; Luque, A; Morte, A | 1 |
| Barbanoj, MJ; Clos, S; Dal-Ré, R; Giménez, S; Lorenzo, JL; Luque, A; Morte, A; Romero, S | 1 |
| Girardi, P; Kotzalidis, GD; Lazanio, S; Manfredi, G; Ruberto, A; Tatarelli, R | 1 |
| Espa-Cervená, K; Houbová, P; Novák, T; Pasková, B; Prasko, J; Vyskocilová, J; Záleský, R | 1 |
| Hogg, S; Jessa, M; Michan, L | 1 |
| Fujita, K; Ichihashi, K; Inoue, K; Okazaki, Y; Tanii, H | 1 |
| Corace, E; De Fazio, P; De Fazio, S; De Sarro, G; Gallelli, L; Garcia, CS | 1 |
| Celik, L; Kaynak, S; Kaynak, T; Kocak, N; Ozerdem, A | 1 |
| Ahn, SC; Choi, TK; Lee, SH; Lee, YJ; Suh, SY; Yook, KH | 1 |
| Matsumoto, H; Tamai, Y | 1 |
| Juřica, J; Žourková, A | 1 |
| Cinconze, M; Concerto, C; Costanzo, MC; Signorelli, MS | 1 |
| Aragão, I; Cardoso, T; Guedes, F; Maia, JM | 1 |
| Orlando, JM | 1 |
| Coimbra, JPC; Coimbra, NC; de Freitas, RL; Dos Anjos-Garcia, T; Falconi-Sobrinho, LL; Laure, CJ; Paschoalin-Maurin, T | 1 |
| Barbui, C; Bighelli, I; Caldwell, DM; Cipriani, A; Davies, SJ; Dawson, S; Dias, S; Furukawa, TA; Guaiana, G; Imai, H; Koesters, M; Meader, N; Pompoli, A; Robertson, L; Tajika, A | 1 |
3 review(s) available for paroxetine and alprazolam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy of generalized anxiety disorder.
Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Paroxetine; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Topics: Adult; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Clonazepam; Desipramine; Diazepam; Fluoxetine; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2023 |
5 trial(s) available for paroxetine and alprazolam
| Article | Year |
|---|---|
Lack of pharmacologic interaction between paroxetine and alprazolam at steady state in healthy volunteers.
Topics: Adult; Alprazolam; Analysis of Variance; Area Under Curve; Chi-Square Distribution; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Humans; Male; Multivariate Analysis; Paroxetine; Psychomotor Performance | 2004 |
Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Topics: Adult; Alprazolam; Analysis of Variance; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Clinical Laboratory Techniques; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Linear Models; Male; Paroxetine; Polysomnography; Self-Assessment; Sleep; Sleep, REM; Surveys and Questionnaires; Time Factors; Wakefulness | 2005 |
Influence of personality disorder on the treatment of panic disorder--comparison study.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Disorders; Personality Inventory; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 2005 |
Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Fluvoxamine; Humans; Meditation; Paroxetine; Program Development; Self Care; Sertraline; Stress, Psychological; Surveys and Questionnaires | 2007 |
Dynamics and persistence of CYP2D6 inhibition by paroxetine.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Depression; Dextromethorphan; Dextrorphan; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Young Adult | 2013 |
20 other study(ies) available for paroxetine and alprazolam
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
Topics: Alprazolam; Biotransformation; Culture Techniques; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Dose-Response Relationship, Drug; Fluvoxamine; Humans; Hydroxylation; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1995 |
An 87-year-old woman taking a benzodiazepine, 1 year later.
Topics: Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Depression; Drug Therapy, Combination; Female; Humans; Paroxetine; Risk | 1999 |
Postpartum depression without delivering a child?
Topics: Alprazolam; Anti-Anxiety Agents; Depression, Postpartum; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Family; Female; Humans; Hysterectomy; Middle Aged; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Suicide, Attempted | 2005 |
Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.
Topics: Adrenergic alpha-Antagonists; Alprazolam; Animals; Anxiety; Citalopram; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Hypnotics and Sedatives; Male; Motor Activity; Panic Disorder; Paroxetine; Periaqueductal Gray; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques; Yohimbine | 2006 |
Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
Topics: Aged; Alprazolam; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Male; Neuroleptic Malignant Syndrome; Paroxetine; Psychiatric Status Rating Scales | 2006 |
Generalised urticaria in a young woman treated with clomipramine and after ingestion of codfish.
Topics: Adult; Alprazolam; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Clomipramine; Drug Eruptions; Female; Food-Drug Interactions; Gadus morhua; Humans; Hypnotics and Sedatives; Meat; Obsessive-Compulsive Disorder; Paroxetine; Urticaria | 2006 |
Disappointment of patients on antidepressant therapy after excimer laser treatment.
Topics: Adult; Alprazolam; Antidepressive Agents; Dry Eye Syndromes; Female; Humans; Keratomileusis, Laser In Situ; Middle Aged; Mydriasis; Myopia; Paroxetine; Patient Satisfaction; Patients; Sertraline; Vision Disorders | 2006 |
11-year-old boy with panic disorder responding to paroxetine.
Topics: Alprazolam; Anti-Anxiety Agents; Child; Humans; Male; Neuropsychological Tests; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2007 |
What kind of diagnosis in a case of mobbing: post-traumatic stress disorder or adjustment disorder?
Topics: Adjustment Disorders; Alprazolam; Anti-Anxiety Agents; Crowding; Diagnosis, Differential; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Middle Aged; Paroxetine; Pregabalin; Stress Disorders, Post-Traumatic | 2013 |
Eosinophilic pneumonia presenting as life-threatening ARDS.
Topics: Adult; Alprazolam; Antidepressive Agents, Second-Generation; Caustics; Cough; Drug Therapy, Combination; Eosinophilia; Eosinophils; Female; Glucocorticoids; Humans; Lye; Paroxetine; Prednisone; Pulmonary Eosinophilia; Radiography, Thoracic; Respiratory Distress Syndrome; Suicide, Attempted; Treatment Outcome; Valproic Acid | 2015 |
Animal Behavior Case of the Month.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Diazepam; Dog Diseases; Dogs; Fear; Fluoxetine; Gabapentin; Male; Noise; Paroxetine; Phobic Disorders | 2017 |
The Rodent-versus-wild Snake Paradigm as a Model for Studying Anxiety- and Panic-like Behaviors: Face, Construct and Predictive Validities.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anxiety; Dose-Response Relationship, Drug; Elapidae; Escape Reaction; Limbic System; Male; Mesocricetus; Models, Animal; Panic; Panic Disorder; Paroxetine; Predatory Behavior; Proto-Oncogene Proteins c-fos | 2018 |